These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30355544)

  • 21. Therapeutic efficacy of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head.
    Spieth K; Gille J; Kaufmann R
    Arch Dermatol; 1999 Sep; 135(9):1035-7. PubMed ID: 10490107
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary cutaneous B-cell lymphoma: treatment with low dose intralesional recombinant interferon-alpha 2A.
    Rubegni P; De Aloe G; Pianigiani E; Lazzi S; Fimiani M
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):70-1. PubMed ID: 10188159
    [No Abstract]   [Full Text] [Related]  

  • 23. Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes.
    El Kassas M; Alboraie M; Elsaeed K; Ahmed Y; El Tahan A; Alhaddad O; Salaheldin M; Kabbash I; El Badry M; Fathy T; El-Serafy M; ElShazly Y; Doss W; Esmat G
    Am J Ther; 2018; 25(6):e776-e779. PubMed ID: 30124480
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991.
    Bouwhuis MG; Suciu S; Testori A; Kruit WH; Salès F; Patel P; Punt CJ; Santinami M; Spatz A; Ten Hagen TL; Eggermont AM
    J Clin Oncol; 2010 May; 28(14):2460-6. PubMed ID: 20385998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case report of an excellent response to interferon- α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments.
    Özdirik B; Tacke F; Benz F; Amthauer H; Fehrenbach U; Roderburg C; Jann H
    Medicine (Baltimore); 2020 Jun; 99(25):e20820. PubMed ID: 32569231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disappearance of a chromosomal abnormality in a young patient with polycythemia vera treated with ropeginterferon alfa-2b.
    Hosoda R; Hashimoto Y; Hara K; Maegaki M; Suzuki S; Hosoda Y; Kawamura K
    Ann Hematol; 2024 Sep; 103(9):3825-3827. PubMed ID: 39052033
    [No Abstract]   [Full Text] [Related]  

  • 27. Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report.
    Maunsell R; Bellomo-Brandão MA
    Sao Paulo Med J; 2018; 136(4):376-381. PubMed ID: 28977096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmunity aids survival in melanoma.
    Senior K
    Lancet Oncol; 2006 Apr; 7(4):289. PubMed ID: 16598882
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.
    Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T
    J Surg Res; 2012 Jan; 172(1):95-101. PubMed ID: 20851413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving role of pegylated interferons in metastatic renal cell carcinoma.
    Choueiri TK; Hutson TE; Bukowski RM
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):823-9. PubMed ID: 14686704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent polycythemia vera and chronic lymphocytic leukemia: treatment response to pegylated interferon alpha 2a.
    Selinger HA; Ballesteros E; Bona R
    Am J Hematol; 2013 Jun; 88(6):535-6. PubMed ID: 23553722
    [No Abstract]   [Full Text] [Related]  

  • 32. Pegylated interferon for the adjuvant treatment of melanoma: FDA approved, but what is its role?
    Sondak VK; Kudchadkar R
    Oncologist; 2012; 17(10):1223-4. PubMed ID: 23002125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.
    Hüsken AC; Tsianakas A; Hensen P; Nashan D; Loquai C; Beissert S; Luger TA; Sunderkötter C; Schiller M
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):71-8. PubMed ID: 22168776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of pegylated interferon--alpha2B on mumps orchitis.
    Pal G
    J Indian Med Assoc; 2013 Sep; 111(9):612-4, 617. PubMed ID: 24968526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
    Goldman S; Pollack IF; Jakacki RI; Billups CA; Poussaint TY; Adesina AM; Panigrahy A; Parsons DW; Broniscer A; Robinson GW; Robison NJ; Partap S; Kilburn LB; Onar-Thomas A; Dunkel IJ; Fouladi M
    Neuro Oncol; 2020 Nov; 22(11):1696-1704. PubMed ID: 32393959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation.
    Dagorne A; Douet-Guilbert N; Quintin-Roue I; Guillerm G; Couturier MA; Berthou C; Ianotto JC
    Ann Hematol; 2013 Mar; 92(3):407-9. PubMed ID: 22941306
    [No Abstract]   [Full Text] [Related]  

  • 37. [Not Available].
    Kucherenko A; Pampukha V; Romanchuk K; Chernushyn S; Bobrova I; Moroz L; Livshits L
    Tsitol Genet; 2016; 50(5):79-84. PubMed ID: 30480920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous follicle centre lymphoma, spindle cell type, presenting with multicentre figurated erythema and complete remission after intralesional injections of ultra-low-dose Interferon alpha-2a.
    Vlahova L; Kempf W; Schön MP; Mitteldorf C
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e223-e225. PubMed ID: 32920866
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential of Pegylated Interferon Alpha-2a in Behçet Uveitis: A Report of Five Cases.
    Bielefeld P; Devilliers H; Deschasse C; Saadoun D; Sève P; Muselier A; Creuzot-Garcher C; Besancenot JF; Bron AM
    Ocul Immunol Inflamm; 2016 Oct; 24(5):599-602. PubMed ID: 25760915
    [No Abstract]   [Full Text] [Related]  

  • 40. [High dose of pegylated interferon alpha-2a for the treatment of genotype1 chronic hepatitis C: a case report].
    Wu CH; Wang LF; Xu XY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):873. PubMed ID: 21138646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.